Completed
Rasburicase for Hyperuricemia
NCT00290992
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hyperuricemia, +11 more
- Locations
-
- Sanofi-Aventis Tokyo, Japan
Clinical trial condition
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
NCT00290992
NCT00850265
NCT00869284
NCT00866203
NCT00452257
NCT00043368
NCT00713882
NCT00326534
NCT00533728